{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:09:09Z","timestamp":1781910549355,"version":"3.54.5"},"reference-count":30,"publisher":"Baishideng Publishing Group Inc.","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Gastrointest Surg"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n                  <jats:p>Hepatocellular carcinoma (HCC) in segments VII and VIII poses technical challenges for both liver resection and radiofrequency ablation (RFA). Robotic-assisted techniques may enhance safety and precision, but comparative evidence remains limited.<\/jats:p>\n                  <jats:p>AIM<\/jats:p>\n                  <jats:p>To compare the clinical outcomes of robotic liver resection (R-LR) and robotic intraoperative RFA (RIO-RFA) for HCC located in liver segments VII and VIII.<\/jats:p>\n                  <jats:p>METHODS<\/jats:p>\n                  <jats:p>We retrospectively analyzed 93 HCC patients in segments VII\/VIII with de novo  (n  = 57) or first recurrent (n  = 36). HCC who underwent R-LR or RIO-RFA between 2015 and 2024. Propensity score matching was performed to reduce selection bias. Primary outcomes were overall survival (OS) and recurrence-free survival (RFS). Kaplan-Meier curves, log-rank tests, and Cox regression were used to identify prognostic factors for OS and RFS.<\/jats:p>\n                  <jats:p>RESULTS<\/jats:p>\n                  <jats:p>In the de novo  group, OS and RFS did not differ significantly between R-LR and RIO-RFA before or after propensity score matching. In contrast, the recurrent group showed significantly improved OS and RFS with R-LR (P  = 0.005 and P  = 0.012, respectively). Subgroup analyses revealed that low-risk de novo  patients with smaller tumors achieved superior OS after R-LR, whereas carefully selected low-risk recurrent patients undergoing RIO-RFA (smaller tumors, absence of complications) achieved outcomes comparable to R-LR. Platelet count, tumor size, and postoperative complications constituted key prognostic factors.<\/jats:p>\n                  <jats:p>CONCLUSION<\/jats:p>\n                  <jats:p>For HCC in challenging liver segments VII and VIII, R-LR and RIO-RFA achieve comparable outcomes in de novo  cases, whereas R-LR confers superior survival in recurrent disease. R-LR should be prioritized for small de novo  HCCs and for recurrent disease overall; RIO-RFA may serve as an effective alternative in carefully selected low-risk recurrent patients. Tumor size, platelet count, and postoperative complications are key prognostic indicators to guide individualized treatment.<\/jats:p>","DOI":"10.4240\/wjgs.v17.i12.113940","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:12:16Z","timestamp":1766621536000},"source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of robotic liver resection and intraoperative radiofrequency ablation for hepatocellular carcinoma in posterior segments VII and VIII"],"prefix":"10.4240","volume":"17","author":[{"given":"Cheng-Ming","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Yin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-Chieh","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Lung","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hong","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Fang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Han","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"B1","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F.   Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. [cited 2025 September 6]. Available from: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/cancers\/11-liver-and-intrahepatic-bile-ducts-fact-sheet.pdf"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092582"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00825-3"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v15.i4.515"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.1211"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051493"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2384"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/16397365"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v16.i11.3400"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08231-0"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-11757-0"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-024-03330-8"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00113"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1559343"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-019-07357-x"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-021-02277-4"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S496470"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000002302"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.991944"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215398"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2021.1933218"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znab340"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1032746"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2011.01.004"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.6358"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.018"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2020.0204"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2018.038"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-024-03466-x"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S152707"}],"container-title":["World Journal of Gastrointestinal Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1948-9366\/full\/v17\/i12\/113940.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/1948-9366\/full\/v17\/i12\/113940.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:13:08Z","timestamp":1766621588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1948-9366\/full\/v17\/i12\/113940.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":30,"journal-issue":{"issue":"12"},"alternative-id":["113940"],"URL":"https:\/\/doi.org\/10.4240\/wjgs.v17.i12.113940","relation":{},"ISSN":["1948-9366"],"issn-type":[{"value":"1948-9366","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,27]]}}}